Customer Service: 866-788-9007
×

RESEARCH
AND DEVELOPMENT

Data Presented at the 42nd Annual Fall Clinical Dermatology Conference®

November 8, 2022

New Data Presented at the 42nd Annual Fall Clinical Dermatology Conference® POSTER #1 Incorporating the 31-gene expression profile test stratifies survival outcomes and leads to improved survival compared to clinicopathologic factors alone: A Surveillance, Epidemiology, and End Results (SEER) Program Collaboration   […]

Read More

DecisionDx-SCC Clinical Impact Study on Utility Presented at the 2022 American Society for Dermatologic Surgery (ASDS)

October 10, 2022

How Mohs surgeons Utilize Prognostic Testing for High-Risk Cutaneous Squamous Cell Carcinoma (SCC): A Clinical Impact Study The study was executed via a clinical impact survey of current American College of Mohs Surgery (ACMS) members with a primary purpose to determine how […]

Read More

Integrating Clinicopathologic Features With The 31-GEP Optimizes Patient Risk-Stratification Compared To Clinicopathologic Features Alone

October 10, 2022

Integrating Clinicopathologic Features with the 31-GEP Optimizes Patient Risk-Stratification Compared to Clinicopathologic Features Alone A recent publication in the Journal of the American Academy of Dermatology (JAAD) highlights the development and validation of an AI algorithm integrating clinicopathological features with a 31-gene […]

Read More

Optimizing Treatment Approaches For Patients

August 18, 2022

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test The objective of this retrospective study was to develop an algorithm by integrating the 31-gene expression profile test with clinicopathologic data for […]

Read More

NOT REGISTERED?
NO PROBLEM!

Sign up for access to our monthly newsletter online
and directly in your inbox each month.

Scroll to Top